Literature DB >> 14559181

Tyrosine kinase signal specificity: lessons from the HGF receptor.

Andrea Bertotti1, Paolo M Comoglio.   

Abstract

There are two major lines of thinking concerning the mechanisms responsible for specificity in receptor tyrosine kinase signalling. On one hand, receptors might provide instructive signals that dictate cell-fate decisions and, on the other, they might generate permissive signals unleashing responses that are inherently defined in the protein repertoire of target cells. Recent data indicate that the signalling activity of the Met receptor for hepatocyte growth factor is affected by association with cell-specific surface molecules, namely the alpha6beta4 integrin, Plexin B1 and CD44. This suggests that integration of cell-restricted expression of receptor partners that modulate kinase outputs with the intrinsic signalling features of receptors is required for specification of biological responses.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14559181     DOI: 10.1016/j.tibs.2003.09.001

Source DB:  PubMed          Journal:  Trends Biochem Sci        ISSN: 0968-0004            Impact factor:   13.807


  12 in total

Review 1.  Plexin structures are coming: opportunities for multilevel investigations of semaphorin guidance receptors, their cell signaling mechanisms, and functions.

Authors:  Prasanta K Hota; Matthias Buck
Journal:  Cell Mol Life Sci       Date:  2012-06-29       Impact factor: 9.261

2.  CD44v6 coordinates tumor matrix-triggered motility and apoptosis resistance.

Authors:  Thorsten Jung; Wolfgang Gross; Margot Zöller
Journal:  J Biol Chem       Date:  2011-03-03       Impact factor: 5.157

Review 3.  MET signalling: principles and functions in development, organ regeneration and cancer.

Authors:  Livio Trusolino; Andrea Bertotti; Paolo M Comoglio
Journal:  Nat Rev Mol Cell Biol       Date:  2010-12       Impact factor: 94.444

Review 4.  MET genetic lesions in non-small-cell lung cancer: pharmacological and clinical implications.

Authors:  Michele Zorzetto; Simona Ferrari; Laura Saracino; Simona Inghilleri; Giulia M Stella
Journal:  Transl Lung Cancer Res       Date:  2012-09

5.  Plexin B1 suppresses c-Met in melanoma: a role for plexin B1 as a tumor-suppressor protein through regulation of c-Met.

Authors:  Laurel Stevens; Lindy McClelland; Alex Fricke; Magali Williamson; Ihsin Kuo; Glynis Scott
Journal:  J Invest Dermatol       Date:  2010-02-18       Impact factor: 8.551

6.  c-Met and its ligand hepatocyte growth factor/scatter factor regulate mature B cell survival in a pathway induced by CD74.

Authors:  Maya Gordin; Melania Tesio; Sivan Cohen; Yael Gore; Frida Lantner; Lin Leng; Richard Bucala; Idit Shachar
Journal:  J Immunol       Date:  2010-07-16       Impact factor: 5.422

7.  Epidermal growth factor receptor plays a significant role in hepatocyte growth factor mediated biological responses in mammary epithelial cells.

Authors:  Alyssa R Bonine-Summers; Mary E Aakre; Kimberly A Brown; Carlos L Arteaga; Jennifer A Pietenpol; Harold L Moses; Nikki Cheng
Journal:  Cancer Biol Ther       Date:  2007-04       Impact factor: 4.742

8.  Specific fate decisions in adult hepatic progenitor cells driven by MET and EGFR signaling.

Authors:  Mitsuteru Kitade; Valentina M Factor; Jesper B Andersen; Akira Tomokuni; Kosuke Kaji; Hirofumi Akita; Agnes Holczbauer; Daekwan Seo; Jens U Marquardt; Elizabeth A Conner; Seung-Bum Lee; Yun-Han Lee; Snorri S Thorgeirsson
Journal:  Genes Dev       Date:  2013-08-01       Impact factor: 11.361

9.  Distinct intracellular signaling mediates C-MET regulation of dendritic growth and synaptogenesis.

Authors:  Kathie L Eagleson; Christianne J Lane; Lisa McFadyen-Ketchum; Sara Solak; Hsiao-Huei Wu; Pat Levitt
Journal:  Dev Neurobiol       Date:  2016-02-11       Impact factor: 3.964

10.  Ellagitannin-rich cloudberry inhibits hepatocyte growth factor induced cell migration and phosphatidylinositol 3-kinase/AKT activation in colon carcinoma cells and tumors in Min mice.

Authors:  Anne-Maria Pajari; Essi Päivärinta; Lassi Paavolainen; Elina Vaara; Tuuli Koivumäki; Ritu Garg; Anu Heiman-Lindh; Marja Mutanen; Varpu Marjomäki; Anne J Ridley
Journal:  Oncotarget       Date:  2016-07-12
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.